Anna W.
- Country
- Poland
- Department
- Klinika Pediatrii i Nefrologii, Uniwersytecki Dziecięcy Szpital Kliniczny w Białymstoku
Research Overview
- Evaluation of Pegcetacoplan for Reducing Proteinuria in Adults and Adolescents with Focal Segmental Glomerulosclerosis
- Evaluation of Rituximab Efficacy in Inducing Remission in Pediatric Idiopathic Nephrotic Syndrome: A Randomized, Placebo-Controlled Trial
- Safety, Tolerability, and Efficacy of Tolvaptan in Pediatric Patients with Autosomal Recessive Polycystic Kidney Disease: A Phase 3b Multicenter Open-label Trial
Data & Insights
Has run more than one trial at 70 of 134 partner sites.
Specializations
Paediatric oncology
Clinical research in acute lymphoblastic leukemia, acute myeloid leukemia, and lymphoblastic lymphoma, with additional involvement in myeloid leukemia in children with Down syndrome and KMT2A-rearranged infant ALL.
- Acute lymphoblastic leukemia
- Acute myeloid leukemia
- Lymphoblastic lymphoma
- Paediatric malignant liver tumours
Therapeutic interests also include hepatoblastoma and hepatocellular carcinoma, with attention to treatment refinement, relapse control, and reduction of treatment-related toxicity in children and adolescents.
Paediatric nephrology
Work in chronic kidney disease, proteinuria, nephrotic syndrome, and primary IgA nephropathy, together with studies in autosomal recessive polycystic kidney disease and iron deficiency anaemia associated with kidney disease.
- Chronic kidney disease
- Proteinuria
- Nephrotic syndrome
- Autosomal recessive polycystic kidney disease
The therapeutic focus extends to preserving renal function, managing protein loss, and addressing complications linked to paediatric kidney disorders.
Endocrinology and diabetes
Clinical trial activity covers type 1 diabetes mellitus, presymptomatic diabetes type 1, and congenital adrenal hyperplasia, alongside studies in growth hormone deficiency.
- Type 1 diabetes mellitus
- Presymptomatic type 1 diabetes
- Congenital adrenal hyperplasia
- Growth hormone deficiency
Research interests include preservation of beta-cell function, modulation of immune-mediated diabetes, endocrine replacement strategies, and support for linear growth in children.
Cardiometabolic and lipid disorders
Investigator involvement includes hypertrophic cardiomyopathy and heterozygous familial hypercholesterolemia, reflecting interest in paediatric cardiovascular and metabolic risk management.
- Hypertrophic cardiomyopathy
- Heterozygous familial hypercholesterolemia
- Nutritional and metabolic diseases
- Type 1 diabetes-related cardiometabolic risk
These studies address exercise limitation, lipid lowering, and early prevention of long-term vascular complications in young patients.
Supportive care and symptom control
Additional trial activity spans chemotherapy-induced nausea and vomiting, neurogenic detrusor overactivity, bowel cleansing, and supportive treatment in paediatric oncology and nephrology.
- Chemotherapy-induced nausea and vomiting
- Neurogenic detrusor overactivity
- Bowel preparation
- Iron deficiency anaemia
Therapeutic interests include symptom relief, urinary symptom management, and improved tolerance of treatment in children requiring chronic care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.